Publications by authors named "N Klebanov"

Article Synopsis
  • Interleukin-4 (IL-4) therapies are changing how inflammatory skin conditions are treated.
  • These targeted therapies focus specifically on IL-4, leading to better outcomes for patients.
  • The advancements in IL-4 treatments represent a significant improvement in managing various inflammatory dermatoses.
View Article and Find Full Text PDF

Several observational studies have demonstrated a consistent pattern of decreased melanoma risk among patients with vitiligo. More recently, this finding has been supported by a suggested genetic relationship between the two entities, with certain variants significantly associated with an increased risk of melanoma, basal cell carcinoma, and squamous cell carcinoma but a decreased risk of vitiligo. We compared 48 associated variants from a recently published GWAS and identified three variants-located in the , , and loci- that correlated with an increased risk for melanoma, basal cell carcinoma, and squamous cell carcinoma and a decreased risk for vitiligo.

View Article and Find Full Text PDF

The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine. While antimalarials have been well-refuted as a treatment for COVID-19, data on these drugs' role in preventing SARS-CoV-2 infection as pre-exposure prophylaxis is more limited. We investigated the efficacy of antimalarial drugs as pre-exposure SARS-CoV-2 prophylaxis in a US tertiary-care center.

View Article and Find Full Text PDF